Sonal Bhatia from Pfizer: Consistency in Data For The Last 5 Years

Sonal Bhatia, MD, Vice President, Global Eliquis Medical Lead, Pfizer, highlighted the significance of the consistency in data over the last five years, in relation to the five-year-anniversary of her team's Aristotle study at the European Society of Cardiology 2016 (ESC). Bhatia further discussed the ACROPOLIS program, a global study comparing apixaban and other anti-coagulants including warfarin, which had shown significant reduction in bleeding. Accoring to Bhatia, having the global purview is critical allowing methods to compare trends for targeted research.